Smart Box With OT Equator Attachment in Retaining Implant-assisted Overdenture for the Atrophic Maxilla.
Smart Box Accompanied With OT Equator Attachment in Retaining Immediately Loaded Inclined Implant Assisted Overdenture for Atrophic Maxilla
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria Faculty of Dentistry
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male patients with comparable age (30- 65 years).
- All patients should have retruded, posteriorly atrophic completely edentulous maxilla with sinus pneumatization leaving less than 7mm bone height posteriorly and a sufficient amount of bone in the inter bicuspids region.
- Opposing mandibular dentate arch including bilateral posterior teeth.
- All patients should have an adequate zone of keratinized mucosa.
- All patients should be free from any intra-oral or systemic diseases that would otherwise affect the osseointegration of dental implants.
- All patients should be well motivated, cooperative, and with adequate manual dexterity necessary to place and remove removable implant prosthesis to provide adequate oral hygiene around the endosseous implants.
Exclusion Criteria:
- Patients with flabby maxillary ridges.
- Patients who are unwilling to accept implant overdentures as a treatment modality.
- Patients with temporomandibular and neuromuscular disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Implant assisted maxillary overdenture
Horseshoe Maxillary Complete overdenture construction (Stabilizing and connecting the Smart Box housing)
|
For each patient, an implant assisted maxillary overdenture will be fabricated using a minimally invasive flapless surgical technique with OT-Equator and Smart Box attachment
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in peri-implant probing depth
Time Frame: Baseline, 3 months, 6 months, 9 months
|
The peri-implant sulcus depth will be measured using a graduated plastic periodontal probe.
|
Baseline, 3 months, 6 months, 9 months
|
|
Change in Clinical Attachment level
Time Frame: Baseline, 3 months, 6 months, 9 months
|
It is the distance from the junction implant/abutment to the most apically probable portion, in millimeters
|
Baseline, 3 months, 6 months, 9 months
|
|
Change in Implant Stability
Time Frame: at baseline and 9 months
|
The Osstell unit records a numeric value of 1-100 which is referred to as the implant stability quotient (ISQ)
|
at baseline and 9 months
|
|
Change in alveolar bone level
Time Frame: at baseline and 9 months
|
The level of alveolar bone around each abutment will be evaluated using CBCT.
|
at baseline and 9 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Overdenture_2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.